Literature DB >> 33486088

Iron homeostasis and disorders revisited in the sepsis.

Qinjie Liu1, Jie Wu2, Xufei Zhang3, Xiuwen Wu4, Yun Zhao5, Jianan Ren6.   

Abstract

Sepsis is a life-threatening condition caused by a dysregulated host-response to inflammation, although it currently lacks a fully elucidated pathobiology. Iron is a crucial trace element that is essential for fundamental processes in both humans and bacteria. During sepsis, iron metabolism is altered, including increased iron transport and uptake into cells and decreased iron export. The intracellular sequestration of iron limits its availability to circulating pathogens, which serves as a conservative strategy against the pathogens. Although iron retention has been showed to have protective protect effects, an increase in labile iron may cause oxidative injury and cell death (e.g., pyroptosis, ferroptosis) as the condition progresses. Moreover, iron disorders are substantial and correlate with the severity of sepsis. This also suggests that iron may be useful as a diagnostic marker for evaluating the severity and predicting the outcome of the disease. Further knowledge about these disorders could help in evaluating how drugs targeting iron homeostasis can be optimally applied to improve the treatment of patients with sepsis. Here, we present a comprehensive review of recent advances in the understanding of iron metabolism, focusing on the regulatory mechanisms and iron-mediated injury in sepsis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ferroptosis; Inflammation; Iron chelator; Iron retention; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 33486088     DOI: 10.1016/j.freeradbiomed.2021.01.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Cardiomyocyte death in sepsis: Mechanisms and regulation (Review).

Authors:  Geping Zhang; Dan Dong; Xianyao Wan; Yongli Zhang
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

Review 2.  Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

Review 3.  Sepsis-Exacerbated Brain Dysfunction After Intracerebral Hemorrhage.

Authors:  Jie Lin; Binbin Tan; Yuhong Li; Hua Feng; Yujie Chen
Journal:  Front Cell Neurosci       Date:  2022-01-21       Impact factor: 5.505

4.  Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction.

Authors:  Zheng Xiao; Bin Kong; Jin Fang; Tianyou Qin; Chang Dai; Wei Shuai; He Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Alteration of osteoclast activity in childhood cancer survivors: Role of iron and of CB2/TRPV1 receptors.

Authors:  Francesca Rossi; Chiara Tortora; Martina Di Martino; Alessandra Di Paola; Daniela Di Pinto; Maria Maddalena Marrapodi; Maura Argenziano; Elvira Pota
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

Review 6.  The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation.

Authors:  Dustin Beyer; Jessica Hoff; Oliver Sommerfeld; Alexander Zipprich; Nikolaus Gaßler; Adrian T Press
Journal:  Mol Med       Date:  2022-07-30       Impact factor: 6.376

7.  The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages.

Authors:  Jie Wu; Qinjie Liu; Xufei Zhang; Miaomiao Tan; Xuanheng Li; Peizhao Liu; Lei Wu; Fan Jiao; Zhaoyu Lin; Xiuwen Wu; Xin Wang; Yun Zhao; Jianan Ren
Journal:  Cell Death Dis       Date:  2022-07-28       Impact factor: 9.685

Review 8.  Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential.

Authors:  Lei Xl; Zhao Gy; Guo R; Cui N
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

9.  Screening of potential key ferroptosis-related genes in sepsis.

Authors:  Shunan Cui; Kun Niu; Yining Xie; Shuo Li; Wenzhi Zhu; Ling Yu; Hongyu Tan
Journal:  PeerJ       Date:  2022-09-13       Impact factor: 3.061

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.